Neonatal & Preterm Infants Enteral Feeding Devices Market find out Growth Potential through Demand Forecast 2030

Neonatal and Preterm Infants Enteral Feeding Devices used to deliver nutrients through a tube for pediatric patients with poor voluntary intake, chronic neurological or mechanical dysphagia or gut dysfunction. Increasing prevalence of chronic disorders in infants is expected to propel growth of the global neonatal and preterm infants enteral feeding devices market over the forecast period. Furthermore, increasing preterm birth rate along with increasing prevalence of chronic disorders in infants is also expected to aid in growth of the market

Increasing preterm birth rate is expected to propel growth of the global neonatal and preterm infants enteral feeding devices market over the forecast period. For instance, according to March of Dimes 2019 report card, the preterm birth rate in the U.S. reached 10.02% in 2018 from 9.63% in 2015.

Moreover, increasing prevalence of chronic disorders in infants is also expected to aid in growth of the market. For instance, according to the study, ‘Prevalence of Pediatric Metabolic Syndrome and Associated Risk Factors among School-Age Children of 10–16 Years Living in District Shimla, Himachal Pradesh, India’, published in Indian Journal of Endocrinology and Metabolism in May 2018, the prevalence of pediatric metabolic syndrome was 3.3% and school-age children with high family monthly income and sedentary lifestyle were at high risk of the disease.

There are no regulatory environment issues associated with the production of enteral nutrition products. Such scenario is expected to offer lucrative growth opportunities for players in the global neonatal and preterm infants enteral feeding devices market.

Moreover, premature infants are more likely to have immature gastrointestinal systems. Thus, development of a universal feeding approach in preterm infants is also expected to aid in growth of the market.

 

Comments

Post a Comment

Popular posts from this blog

Mantle Cell Lymphoma Treatment Market will generate new growth opportunities 2023-2030

Image
Mantle cell lymphoma (MCL) is a type of non-Hodgkin lymphoma (NHL) that arises from abnormal B lymphocytes (a type of white blood cell) known as mantle cells. It is considered an aggressive subtype of NHL, and its treatment typically involves a combination of different approaches, including chemotherapy, immunotherapy, targeted therapy, and stem cell transplantation. Here is a detailed overview of the treatment options for mantle cell lymphoma : Chemotherapy: Chemotherapy drugs are commonly used as the initial treatment for MCL. The specific chemotherapy regimens may vary, but commonly used combinations include R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone), hyper-CVAD (cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with high-dose methotrexate and cytarabine), or Bendamustine combined with rituximab (BR). Chemotherapy is typically administered in cycles over several months. Immunotherapy: ...
Read more

Phosphodiesterase Enzyme (PDE) Inhibitors Market 2023 Report Contains Key Vendor Analysis, Vendor Landscape and Forecast to 2030

Image
Phosphodiesterase (PDE) inhibitors are a class of drugs that act on the phosphodiesterase enzymes , specifically the cyclic nucleotide phosphodiesterases. These enzymes are responsible for the degradation of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), which are important intracellular signaling molecules involved in various physiological processes. By inhibiting the activity of PDE enzymes, PDE inhibitors increase the levels of cAMP and cGMP in cells, leading to a variety of pharmacological effects. PDE inhibitors are used to treat a range of conditions, including erectile dysfunction, pulmonary arterial hypertension, and chronic obstructive pulmonary disease. They are available in different formulations, including oral tablets, sublingual tablets, and inhalers. There are several types of PDE enzymes, and PDE inhibitors are classified based on their selectivity for specific PDE enzyme subtypes. The major PDE inhibitors used in clinical practice ...
Read more

Enteral Nutrition Market will generate new growth opportunities 2023-2030

Image
Enteral nutrition is a method of providing nutrition directly into the gastrointestinal tract. It involves the delivery of a liquid formula containing nutrients through a tube, which can be inserted through the nose (nasogastric or nasoenteric tube) or directly into the stomach or small intestine (gastrostomy or jejunostomy tube). Enteral nutrition is typically used when a person is unable to consume an adequate amount of food orally or has a dysfunctional or non-functioning gastrointestinal tract. It may be used in various medical conditions such as: Inability to swallow: Patients who have difficulty swallowing due to conditions like stroke, neurological disorders, or head and neck cancers may require enteral nutrition to ensure adequate nutrition. Gastrointestinal disorders: Individuals with conditions such as Crohn's disease, short bowel syndrome, or malabsorption disorders may have difficulty absorbing nutrients from food, and enteral nutri...
Read more